Table 3.
Relative effects in Clinical Global Impression Improvement (CGI-I) and Clinical Global Impression Severity (CGI-S) improvement by baseline CGI-S for orally disintegrating olanzapine tablet compared to standard-coated olanzapine tablet
| Final visit (2 weeks) |
||||
|---|---|---|---|---|
| Relative effect | 95% confidence interval | |||
| Baseline | lower | upper | ||
| CGI-I | (n = 454) | 0.5085 | 0.4587 | 0.5584 |
| CGI-S | ≤4 (n = 25) | 0.6233 | 0.4110 | 0.8355 |
| 5 (n = 167) | 0.4784 | 0.3967 | 0.5601 | |
| 6 (n = 232) | 0.4338 | 0.3626 | 0.5050 | |
| 7 (n = 30) | 0.2159 | 0.0161 | 0.4158 | |
Abbreviations: CGI-I, Clinical Global Impression, Improvement, CGI-S, Clinical Global Impression, Severity; ODT, orally disintegrating olanzapine tablet; SOT, standard-coated olanzapine tablet.